vs
Side-by-side financial comparison of FrontView REIT, Inc. (FVR) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.
Pulmonx Corp is the larger business by last-quarter revenue ($20.6M vs $16.5M, roughly 1.2× FrontView REIT, Inc.). FrontView REIT, Inc. runs the higher net margin — -24.9% vs -66.3%, a 41.4% gap on every dollar of revenue.
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
FVR vs LUNG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $16.5M | $20.6M |
| Net Profit | $-4.1M | $-13.7M |
| Gross Margin | — | 77.9% |
| Operating Margin | — | -40.9% |
| Net Margin | -24.9% | -66.3% |
| Revenue YoY | — | -8.7% |
| Net Profit YoY | — | 5.5% |
| EPS (diluted) | $-0.19 | $-0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $20.6M | ||
| Q4 25 | $16.5M | $22.6M | ||
| Q3 25 | $16.8M | $21.5M | ||
| Q2 25 | $17.6M | $23.9M | ||
| Q1 25 | $16.2M | $22.5M | ||
| Q4 24 | — | $23.8M | ||
| Q3 24 | $14.5M | $20.4M | ||
| Q2 24 | — | $20.8M |
| Q1 26 | — | $-13.7M | ||
| Q4 25 | $-4.1M | $-10.4M | ||
| Q3 25 | $4.0M | $-14.0M | ||
| Q2 25 | $-2.9M | $-15.2M | ||
| Q1 25 | $-833.0K | $-14.4M | ||
| Q4 24 | — | $-13.2M | ||
| Q3 24 | $-2.4M | $-14.1M | ||
| Q2 24 | — | $-15.3M |
| Q1 26 | — | 77.9% | ||
| Q4 25 | — | 77.6% | ||
| Q3 25 | — | 74.7% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 72.5% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 73.7% | ||
| Q2 24 | — | 73.7% |
| Q1 26 | — | -40.9% | ||
| Q4 25 | — | -43.8% | ||
| Q3 25 | — | -66.9% | ||
| Q2 25 | — | -62.0% | ||
| Q1 25 | — | -64.6% | ||
| Q4 24 | — | -56.5% | ||
| Q3 24 | — | -69.3% | ||
| Q2 24 | — | -75.2% |
| Q1 26 | — | -66.3% | ||
| Q4 25 | -24.9% | -46.1% | ||
| Q3 25 | 23.9% | -64.9% | ||
| Q2 25 | -16.5% | -63.6% | ||
| Q1 25 | -5.1% | -64.1% | ||
| Q4 24 | — | -55.4% | ||
| Q3 24 | -16.7% | -69.4% | ||
| Q2 24 | — | -73.7% |
| Q1 26 | — | $-0.33 | ||
| Q4 25 | $-0.19 | $-0.25 | ||
| Q3 25 | $0.19 | $-0.34 | ||
| Q2 25 | $-0.16 | $-0.38 | ||
| Q1 25 | $-0.06 | $-0.36 | ||
| Q4 24 | — | $-0.33 | ||
| Q3 24 | — | $-0.36 | ||
| Q2 24 | — | $-0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.5M | $61.6M |
| Total DebtLower is stronger | $314.3M | $37.3M |
| Stockholders' EquityBook value | $391.2M | $45.8M |
| Total Assets | $854.4M | $120.0M |
| Debt / EquityLower = less leverage | 0.80× | 0.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $61.6M | ||
| Q4 25 | $13.5M | $69.8M | ||
| Q3 25 | $19.6M | $76.5M | ||
| Q2 25 | $8.4M | $75.5M | ||
| Q1 25 | $3.3M | $74.6M | ||
| Q4 24 | — | $70.9M | ||
| Q3 24 | — | $63.3M | ||
| Q2 24 | — | $63.5M |
| Q1 26 | — | $37.3M | ||
| Q4 25 | $314.3M | $37.1M | ||
| Q3 25 | $307.1M | $37.1M | ||
| Q2 25 | $316.9M | $37.1M | ||
| Q1 25 | $310.2M | $37.2M | ||
| Q4 24 | — | $37.2M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $37.2M |
| Q1 26 | — | $45.8M | ||
| Q4 25 | $391.2M | $54.1M | ||
| Q3 25 | $385.2M | $60.0M | ||
| Q2 25 | $369.9M | $69.1M | ||
| Q1 25 | $324.7M | $77.7M | ||
| Q4 24 | — | $85.8M | ||
| Q3 24 | $1.0K | $93.9M | ||
| Q2 24 | — | $101.2M |
| Q1 26 | — | $120.0M | ||
| Q4 25 | $854.4M | $129.3M | ||
| Q3 25 | $846.8M | $138.3M | ||
| Q2 25 | $856.5M | $147.2M | ||
| Q1 25 | $860.8M | $150.7M | ||
| Q4 24 | — | $162.8M | ||
| Q3 24 | $1.0K | $167.4M | ||
| Q2 24 | — | $172.6M |
| Q1 26 | — | 0.82× | ||
| Q4 25 | 0.80× | 0.69× | ||
| Q3 25 | 0.80× | 0.62× | ||
| Q2 25 | 0.86× | 0.54× | ||
| Q1 25 | 0.96× | 0.48× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $42.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | $-7.1M | ||
| Q3 25 | $8.3M | $-8.2M | ||
| Q2 25 | $9.3M | $-3.9M | ||
| Q1 25 | $8.1M | $-13.2M | ||
| Q4 24 | — | $-6.7M | ||
| Q3 24 | — | $-7.2M | ||
| Q2 24 | — | $-5.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-7.1M | ||
| Q3 25 | — | $-8.3M | ||
| Q2 25 | — | $-4.0M | ||
| Q1 25 | — | $-13.5M | ||
| Q4 24 | — | $-6.8M | ||
| Q3 24 | — | $-7.7M | ||
| Q2 24 | — | $-6.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | -31.4% | ||
| Q3 25 | — | -38.4% | ||
| Q2 25 | — | -16.6% | ||
| Q1 25 | — | -60.0% | ||
| Q4 24 | — | -28.8% | ||
| Q3 24 | — | -37.6% | ||
| Q2 24 | — | -30.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
